series-c-plus
Stage
3
Investors
About
Synchron is a neurotechnology company developing minimally invasive, endovascular brain-computer interfaces (BCIs) to restore communication and independence for people with severe motor impairments.
Explore Synchron's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.